ConductScience.org, home
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
API referenceFor AI assistants

Trial · NCT02239120

Adverse events1,284

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,284

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherNasopharyngitisInfections and infestationsDabigatran Etexilate 110 or 150 Milligram (mg)1732,676
otherNasopharyngitisInfections and infestationsAcetylsalicylic Acid, Aspirin (ASA) 100 mg1702,674
otherAtrial fibrillationCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)1362,676
otherAtrial fibrillationCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg1282,674
seriousAnaemiaBlood and lymphatic system disordersDabigatran Etexilate 110 or 150 Milligram (mg)72,676
seriousAnaemiaBlood and lymphatic system disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg32,674
seriousPancytopeniaBlood and lymphatic system disordersDabigatran Etexilate 110 or 150 Milligram (mg)12,676
seriousPancytopeniaBlood and lymphatic system disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg02,674
seriousAcute myocardial infarctionCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)112,676
seriousAcute myocardial infarctionCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg82,674
seriousAngina pectorisCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)32,676
seriousAngina pectorisCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg42,674
seriousAngina unstableCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)42,676
seriousAngina unstableCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg22,674
seriousAortic valve incompetenceCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)12,676
seriousAortic valve incompetenceCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg02,674
seriousAtrial fibrillationCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)242,676
seriousAtrial fibrillationCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg202,674
seriousAtrial fibrillation or atrial flutterCardiac disordersDabigatran Etexilate 110 or 150 Milligram (mg)342,676
seriousAtrial fibrillation or atrial flutterCardiac disordersAcetylsalicylic Acid, Aspirin (ASA) 100 mg292,674

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02239120/events

API referenceFor AI assistants